Growth hormone therapy and quality of life in adults and children

PharmacoEconomics

Volumn 22, Issue 8, 2004, Pages 499-523

  Radcliffe, Deborah J ^a   Pliskin, Joseph S ^b,c   Silvers, J B ^d   Cuttler, Leona ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADAPTATION; ADULTHOOD; BODY BUILD; CHILDHOOD; COMORBIDITY; COST CONTROL; DRUG SAFETY; ECONOMIC ASPECT; GROWTH HORMONE DEFICIENCY; HEALTH CARE COST; HISTORY; HORMONAL THERAPY; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SUBSTITUTION THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME; WELLBEING;

EID: 3042822405     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200422080-00003     Document Type: Review

References (130)

1. Albertsson-Wikland K, Larsson A. Increased availability of human growth hormone: a challenge for health economics. Int J Technol Assess Health Care 1988; 4 (4): 629-33
2. Lantos J, Siegler M, Cuttler L. Ethical issues in growth hormone therapy. JAMA 1989 Feb 17; 261 (7): 1020-4
3. Drug and Therapeutics Committee of the LWPES. Guidelines for the use of growth hormone in children with short stature: a report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995 Dec; 127 (6): 857-67
4. Considerations related to the use of recombinant human growth hormone in children. American Academy of Pediatrics Committee on Drugs and Committee on Bioethics. Pediatrics 1997 Jan; 99 (1): 122-9
5. AACE. AACE clinical practice guidelines for growth hormone use in adults and children. Endocr Pract 1998; 4: 165-73
6. Rosenfield RL, Cuttler L. Somatic growth and maturation. In: Degroot LJ, Jameson JL, editors. Endocrinology. 4th ed. Philadelphia (PA): WB Saunders, 2001: 477-502
7. Frasier SD, Foley Jr TP. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metab 1994 Jun; 78 (6): 1277-9
8. Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 1999 Dec; 84 (12): 4307-16
9. Finkelstein B, Imperiale T, Speroff T, et al. The effect of growth hormone therapy on height in children with idiopathic short stature: a meta analysis. Arch Pediatr Adolesc Med 2002; 156: 230-40
10. Voss LD. Growth hormone therapy for the short normal child: who needs it and who wants it?: the case against growth hormone therapy. J Pediatr 2000 Jan; 136 (1): 103-6
11. Saenger P. Growth hormone therapy for the short normal child: who needs it and who wants it?: the case in support of growth hormone therapy. J Pediatr 2000; 136: 106-9
12. Kelnar CJ, Albertsson-Wikland K, Hintz RL, et al. Should we treat children with idiopathic short stature? Horm Res 1999; 52 (3): 150-7
13. Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med 1999 Oct 14; 341 (16): 1206-16
14. Barkan AL, Clemmons DR, Molitch ME, et al. Growth hormone therapy for hypopituitary adults: time for re-appraisal. Trends Endocrinol Metab 2000 Aug; 11 (6): 238-45
15. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998 Feb; 83 (2): 382-95
16. Society for Endocrinology and The Royal College of Physicians. Health technology appraisal of human growth hormone replacement in adults: professional submission to the National for Clinical Excellence 2001 [online]. Available from URL: http://www.endocrinology.org/SFE/NICEsubmission.htm. [Accessed 2004 Mar 5]
17. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000 Nov; 85 (11): 3990-3
18. Growth Hormone Research Society. Invited report of a workshop: consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998; 83 (2): 379-81
19. Sizonenko P, Clayton PE, Cohen P. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Growth Horm IGF Res 2001; 11: 137-65
20. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995 May; 80 (5): 1532-40
21. Cook D. Shouldn't adults with growth hormone deficiency be offered growth hormone replacement therapy? Ann Intern Med 2002; 137 (3): 197-201
22. Frohman LA. Controversy about treatment of growth hormone-deficient adults: a commentary. Ann Intern Med 2002; 137 (3): 202-4
23. Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995 Nov; 80 (11): 3292-7
24. Cuttler L, Silvers JB, Singh J, et al. Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA 1996 Aug 21; 276 (7): 531-7
25. AACE Growth Hormone Task Force. American association of clinical endocrinologists medical guideline for clinical practice for growth hormone use in adults and children: 2003 update. Endocr Pract 2003; 9 (1): 65-76
26. Grumbach MM. Growth hormone therapy and the short end of the stick. N Engl J Med 1988 Jul 28; 319 (4): 238-41
27. Persico N, Postlewaite A, Silverman D. The effect of adolescent experience on labor market outcomes: the case of height. Philadelphia (PA): University of Pennsylvania, 2002
28. Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998: 132 (2): 319-24
29. Kranzler JH, Rosenbloom AL, Proctor B, et al. Is short stature a handicap?: a comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr 2000 Jan; 136 (1): 96-102
30. Sandberg DE. Should short children who are not deficient in growth hormone be treated? West J Med 2000 Mar; 172 (3): 186-9
31. Sandberg DE, Brook AE, Campos SP. Short stature: a psychosocial burden requiring growth hormone therapy? Pediatrics 1994 Dec; 94 (6 Pt 1): 832-40
32. Growth hormone for normal short children. Med Lett Drugs Ther 2003 Nov 10; 45 (1169): 89-90
33. Ranke MB. Growth hormone therapy in children: when to stop? Horm Res 1995; 43 (4): 122-5
34. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care 1992 Jun; 30 (6): 473-83
35. McEwen J. The Nottingham Health Profile. In: Walker SR, Rosser RM, editors. Quality of life assessment and application. Lancaster: MTP Press, 1987
36. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson DE, Furberg, et al., editors. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq, 1984
37. Asberg M, Perris C, Schalling D, et al. The CPRS: development and application of a psychiatric rating scale. Acta Psychiatr Scand Suppl 1978; (271): 5-27
38. Derogatis LR, Cleary PA. Conformation of the dimensional structure of the SCL-90: a study in contrast validation. J Clin Psychol 1977; 33: 981
39. Goldberg DP. Manual of the general health questionnaire. Slough: NFER Publishing Company, 1978
40. Hunt SM, McKenna SP, Doward LC. Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol (Copenh) 1993 Jun; 128 Suppl. 2: 37-40
41. McKenna SP, Doward LC, Alonso J, et al. The QOL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 1999 Jun; 8 (4): 373-83
42. Haverkamp F, Noeker M. 'Short stature in children: a questionnaire for parents': a new instrument for growth disorder-specific psychosocial adaptation in children. Qual Life Res 1998 Jul; 7 (5): 447-55
43. Wiklund I, Wiren L, Erling A, et al. A new self-assessment questionnaire to measure well-being in children, particularly those of short stature. Qual Life Res 1994 Dec; 3 (6): 449-55
44. Garratt A, Schmidt L, Mackintosh A, et al. Quality of life measurement: bibliographic study of patient assessed health outcomes. BMJ 2002 Jun 15; 324: 1417-22
45. Frost MH, Sloan JA. Quality of life measurements: a soft outcome - or is it? Am J Manag Care 2002 Dec; 8 (18 Suppl.): S574-9
46. Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000 Jan; 17(1): 13-35
47. Brazier J. The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation. Pharmacoeconomics 1995 May; 7(5): 403-15
48. Marra CA, Levine M, McKerrow R, et al. Overview of health-related quality-of-life measures for pediatric patients: application in the assessment of pharmacotherapeutic and pharmacoeconomic outcomes. Pharmacotherapy 1996 Sep-Oct; 16 (5): 879-88
49. Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics 1999 Dec; 16 (6): 605-25
50. Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr. Aug 2001; 22 (4): 248-56
51. Eiser C, Morse R. A review of measures of quality of life for children with chronic illness. Arch Dis Child 2001 Mar; 84: 205-11
52. Murray RD, Shalet SM. The use of self-rating questionnaires as a quantitative measure of quality of life in adult growth hormone deficiency. J Endocrinol Invest 1999; 22 (5 Suppl.): 118-26
53. Cuneo RC, Judd S, Wallace JD, et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1998 Jan; 83 (1): 107-16
54. Barkan AL. The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism? J Clin Endocrinol Metab 2001 May; 86 (5): 1905-7
55. Holmes SJ, Shalet SM. Characteristics of adults who wish to enter a trial of growth hormone replacement. Clin Endocrinol (Oxf) 1995 Jun; 42 (6): 613-8
56. Rotnem D, Cohen DJ, Hintz R, et al. Psychological sequelae of relative "treatment failure" for children receiving human growth hormone replacement. J Am Acad Child Psychiatry 1979 Summer; 18 (3): 505-20
57. Siegel PT. The psychological adjustment of short children and normal controls. In: Brian S, Louis U, editors. Growth stature and adaptation: behavioral, social and cognitive aspects of growth delay. Chapel Hill (NC): University of North Carolina, 1994
58. Schmidt S, Petersen C, Bullinger M. Coping with chronic disease from the perspective of children and adolescents-a conceptual framework and its implications for participation. Child Care Health Dev 2003; 29 (1): 63-75
59. Spirito A, Stark L, Williams C. Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol 1988; 13: 555-74
60. Amer KS. A conceptual framework for studying child adaptation to type 1 diabetes. Issues Compr Pediatr Nurs 1999; 22 (13-25): 13-25
61. Noeker M, Haverkamp F. Adjustment in conditions with short stature: a conceptual framework. J Pediatr Endocrinol Metab 2000; 13 (9): 1585-94
62. Erling A, Wiklund I, Albertsson Wikland K. Prepubertal children with short stature have a different perception of their well-being and stature than their parents. Qual Life Res 1994; 3: 425-9
63. Rosen T, Bengtsson BA. Premature mortality due to cerebrovascular disease in hypopituitarism. Lancet 1990; 336: 285-8
64. Dean HJ, McTaggart TL, Fish DG, et al. The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child 1985 Nov; 139 (11): 1105-10
65. Rosen T, Wiren L, Wilhelmsen L. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994; 49: 765-71
66. Badia X, Lucas A, Sanmarti A, et al. One-year follow-up of quality of life in adults with untreated growth hormone deficiency. Clin Endocrinol (Oxf) 1998 Dec; 49 (6): 765-71
67. McGauley GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 1989; 356: 70-2
68. Beck A, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-82
69. Hamilton M. A rating scale for depression. J Neurosurg Psychiatry 1960; 23: 56-9
70. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974; 19 (1): 1-15
71. Kellner R. Part 1: improvement criteria drug trials with neurotic patients. Psychol Med 1971; 1: 416-21
72. Butcher J, Dahlstrom W, Graham J. Manual for the restandardized Minnesota Multiphasic Personality Inventory: MMPI-2. Minneapolis (MN): University of Minnesota Press, 1989
73. NcNair D, Lorr M, Droppleman L. Profile of mood states: manual. San Diego (CA): Educational and Testing Service, 1981
74. Endicott J, Spitzer R. A diagnostic review: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-44
75. Spielberger C, Gorsuch R, Lushene R. Manual for the state-trait anxiety inventory: STAI. Palo Alto (CA): Consulting Psychologists Press, 1970
76. Degerblad M, Almkvist O, Grunditz R, et al. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 1990 Aug; 123 (2): 185-93
77. Sjoberg L, Svensson E, Persson L. The Measurement of mood. Scand J Phychol 1979; 20: 1-18
78. Whitehead HM, Boreham C, McIlrath EM, et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 1992 Jan; 36 (1): 45-52
79. Bengtsson BA, Eden S, Lonn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993 Feb; 76 (2): 309-17
80. Mardh G, Lundin K, Borg G, et al. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinol Metab 1994; 1 Suppl.: 43-9
81. Burman P, Broman JE, Hetta J, et al. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995 Dec; 80 (12): 3585-90
82. Beshyah SA, Freemantle C, Shahi M, et al. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1995 Jan; 42 (1): 73-84
83. Attanasio AF, Lamberts SW, Matranga AM, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997 Jan; 82 (1): 82-8
84. Verhelst J, Abs R, Vandeweghe M, et al. Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1997; 47 (4): 485-94
85. Wallymahmed M, Foy P, Shaw D, et al. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol 1997; 47 (4): 439-46
86. Baum HB, Katznelson L, Sherman JC, et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1998 Sep; 83 (9): 3184-9
87. Deijen JB, de Boer H, van der Veen EA. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998 Jan; 23 (1): 45-55
88. Florkowski C, Stevens I, Joyce P, et al. Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: a randomized cross-over trial. Psychoneuroendocrinology 1998; 23 (1): 57-63
89. Cooper P, Osborn M, Gath D, et al. Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry 1982; 141: 68-75
90. Giusti M, Meineri I, Malagamba D, et al. Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adult-onset growth hormone deficiency. Eur J Clin Invest 1998 Jan; 28 (1): 13-9
91. De Novaes Soares C, Musolino N, Neto M, et al. Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. Arq Neuropsiquiatr 1999; 57 (2-A): 182-9
92. Vahl N, Juul A, Jorgensen JO, et al. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 2000 May; 85 (5): 1874-81
93. Bengtsson BA, Abs R, Bennmarker H, et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J Clin Endocrinol Metab 1999 Nov; 84 (11): 3929-35
94. Monson JP, Abs R, Bengtsson BA. Growth hormone deficiency and replacement in elderly hypopituitary adults. Clin Endocrinol (Oxf) 2000; 53 (3): 281-9
95. Davies JS, Obuobie K, Smith DA. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners. Endocrinology 2002; 52 (3): 295-303
96. Gibney J, Wallace JD, Spinks T. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metab 1999; 84: 2596-602
97. Gilchrist FJ. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QOL) of GH-deficient adults. Clin Endocrinol 2002; 57: 363-70
98. Rosen T, Johannson G, Mattson A, et al. Growth hormone (GH) replacement therapy produces a sustained improvement in quality of life in hypopituitary adults with GH deficiency: analysis of the KIMS database [abstract no. P1-220]. The 84th Annual Endocrine Society Meeting; 2002 Jun 19-22; San Francisco (CA)
99. Ahmad AM, Hopkins MT, Thomas J, et al. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Clin Endocrinol (Oxf) Jun 2001; 54 (6): 709-17
100. Murray RD, Skillicorn CJ, Howell SJ, et al. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clin Endocrinol (Oxf) 1999 Jun; 50 (6): 749-57
101. Murray RD, Skillicorn CJ, Howell SJ, et al. Influences on quality of life in GH deficient adults and their effect on response to treatment. Clin Endocrinol (Oxf) 1999 Nov; 51 (5): 565-73
102. Murray RD, Darzy KH, Gleeson HK, et al. GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 2002; 87 (1): 129-35
103. Wiren L, Johannsson G, Bengtsson BA. A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood. J Clin Endocrinol Metab 2001 Aug; 86 (8): 3494-8
104. Rotnem D, Genel M, Hintz RL, et al. Personality development in children with growth hormone deficiency. J Am Acad Child Psychiatry 1977 Summer; 16 (3): 412-26
105. Stabler B, Siegel PT, Clopper RR, et al. Behavior change after growth hormone treatment of children with short stature. J Pediatr 1998 Sep; 133 (3): 366-73
106. Theunissen NC, Kamp GA, Koopman HM. Quality of life and self-esteem in children treated for idiopathic short stature. J Pediatr 2002; 140: 507-15
107. Boulton TJ, Dunn SM, Quigley CA, et al. Perceptions of self and short stature: effects of two years of growth hormone treatment. Acta Paediatr Scand Suppl 1991; 377: 20-7
108. Downie AB, Mulligan J, McCaughey ES, et al. Psychological response to growth hormone treatment in short normal children. Arch Dis Child 1996 Jul; 75 (1): 32-5
109. Voss LD, Mulligan J. The short normal child in school: self-esteem, behavior, and attainment (The Wessex Growth Study). In: Stabler B, Underwood LE, editors. Growth, stature, and adaptation. Chapel Hill (NC): University of North Carolina at Chapel Hill, 1994: 47-64
110. Zimet GD, Owens R, Dahms W, et al. Psychosocial outcome of children evaluated for short stature. Arch Pediatr Adolesc Med 1997 Oct; 151 (10): 1017-23
111. Zimet GD, Cutler M, Litvene M, et al. Psychological adjustment of children evaluated for short stature: a preliminary report. J Dev Behav Pediatr Aug 1995; 16 (4): 264-70
112. Bryant J, Loveman E, Chase D, et al. Clinical effectiveness and cost effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health Technol Assess 2002; 6 (19): 1-106
113. Finkelstein BS, Silvers JB, Marrero U, et al. Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature. JAMA 1998 Mar 4; 279 (9): 663-8
114. Molitch ME. Diagnosis of GH deficiency in adults: how good do the criteria need to be? J Clin Endocrinol Metab 2002 Feb; 87 (2): 473-6
115. Jorgensen JO. Two hot topics in the field of GH therapy: quality of life in hypopituitary adults, and clinical implications of the somatopause. Report from an interactive discussion. J Endocrinol Invest 1999; 22 (5 Suppl.): 150-6
116. Prescription drug expenditures in 2000: the upward trend continues. The National Institute for Health Care Management Research and Educational Foundation [online]. Available from URL: http://www.nihcm.org [Accessed 2004 Mar 4]
117. US Census Bureau. US population: the basics. Washington, DC: Population Reference Bureau, 2002
118. Sanmarti A, Lucas A, Hawkins F, et al. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study): socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group. Eur J Endocrinol 1999 Nov; 141 (5): 481-9
119. Ho K. Growth hormone deficiency in adults. In: Degroot LJ, Jameson JL, editors. Endocrinology. 4th ed. Philadelphia (PA): WB Saunders, 2001: 520-7
120. Ehrnborg C, Haakkart-Van Roijen L, Jonsson B. Cost of illness in adult patients with hypopituitarism. Pharmacoeconomics 2000; 17 (6): 621-8
121. Drake WM, Howell SJ, Monson JP, et al. Optimizing GH therapy in adults and children. Endocr Rev 2001; 22 (4): 425-50
122. Shalet SM. Growth hormone deficiency and replacement in adults. BMJ 1996 Aug 10; 313 (7053): 314
123. Hakkaart-van Roijen L, Beckers A, Stevenaert A, et al. The burden of illness of hypopituitary adults with growth hormone deficiency. Pharmacoeconomics 1998 Oct; 14 (4): 395-403
124. Busschbach JJ, Rikken B, Grobbee DE, et al. Quality of life in short adults. Horm Res 1998; 49 (1): 32-8
125. Hernberg-Stahl E, Luger A, Abs R, et al. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab 2001 Nov; 86 (11): 5277-81
126. Dixon S, McEwan P, Lacey L. Preliminary cost-effectiveness model of treatment with genotropin in adults with growth hormone deficiency in the United Kingdom. Paper presented at the 84th Annual Endocrine Society Meeting; 2002 Jun 19-22; San Francisco (CA)
127. Growth Hormone Research Society. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 2001; 86 (6): 1868-70
128. Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 2002; 6 (18): 1-168
129. Landsburg S. Short changed: why do tall people make more money? [online]. Available from URL: http://slate.msn.com [Accessed 2003 Feb 20]
130. Pliskin JS. Towards better decision making in growth hormone therapy. Horm Res 1999; 51 Suppl. 1: 30-5